14
Views
0
CrossRef citations to date
0
Altmetric
Editorial

IGF-I in early-stage Alzheimer’s diesease: a potential therapeutic target?

, &
Pages 97-99 | Published online: 10 Jan 2014
 

Acknowledgements

The authors thank Elise Graux and Bernadette Bresson-Lescure (Plateforme IFR 65 INSERM) for contributing to hormone assays. They thank all the coauthors of the SIGAL study: Benoît Funalot, Nadège Brunel, Joel Coste, Laurent Quinquis., Cécile Viollet, Joel Belmin, Pierre Jouanny, Florence Pasquier, Jean-Marc Treluyer and Yves le Bouc. They thank Jean-Sébastien Vidal for his help with the English language review. They also thank Maria Rego-lopes for contributing to data collection.

Financial & competing interests disclosure

The SIGAL study was supported by a grant from the French Ministry of Health (PHRCN 2006) SIGAL (Study of IGF system on Alzheimer’s disease) and Inserm. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 608.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.